A groundbreaking study has discovered a way to predict whether patients with triple-negative breast cancer (TNBC) will respond well to...
Vous n'êtes pas connecté
A new study has identified a set of plasma proteins that can predict whether patients with triple-negative breast cancer (TNBC) will respond to immunotherapy. By analysing blood samples from 195 TNBC patients, researchers discovered that proteins like ARG1, NOS3, and CD28 are strongly linked to treatment outcomes. The team also developed a predictive model, the [...]
A groundbreaking study has discovered a way to predict whether patients with triple-negative breast cancer (TNBC) will respond well to...
A groundbreaking study has discovered a way to predict whether patients with triple-negative breast cancer (TNBC) will respond well to...
Study finds specific genes that help predict how melanoma patients will respond to immunotherapy, paving the way for more personalized cancer...
A new review reveals how lactate and its derivative lactylation process drive breast cancer progression, opening new therapeutic possibilities. The...
Weight loss has been associated with a lower risk of breast cancer development and improved outcomes for those diagnosed.
A new study may offer a breakthrough for patients with advanced melanoma who don’t respond to current immunotherapy treatments. The research,...
Researchers at Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and University of California San Diego Health have discovered that...
Researchers at Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and University of California San Diego Health have discovered that...
A new global study from Tulane University has found that pharmacists and community health workers are the most successful at helping patients manage...
A new global study from Tulane University has found that pharmacists and community health workers are the most successful at helping patients manage...